Apotex Inc
A Senior Scientific Leader in Formulation Development drives the end-to-end development, optimization, and scale-up of stable solid oral dosage forms suitable for commercial production. The role involves applying Quality-by-Design principles, managing regulatory documentation, and collaborating with manufacturing operations to successfully launch new pharmaceutical products.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Apotex Inc.
22% below the average for this role